OECD Illicit Trade Week: Business Pushes Stronger Public-Private Action

Business at OECD brought a strong private sector delegation to the OECD Forum on Countering Illicit Trade and its related Working Party. In this context, we advanced proposals to complement OECD work on online marketplaces and Free Trade Zones, including stronger information-sharing across supply chains and governments, as well as exploring controls on critical raw materials and precursors. We also support the OECD’s new workstream on non-counterfeit illicit trade, broadening the focus beyond counterfeit goods and helping to drive more coordinated, cross-sector policy approaches while addressing gaps in enforcement frameworks. 

Our Executive Director Hanni Rosenbaum provided opening remarks alongside the OECD Deputy Secretary-General Fabrizia Lapecorella and the Co-Chair of the OECD Working Party on Countering Illicit Trade and the U.S. Department of Homeland Security's James Rockas.

Amazon's Kebharu Smith provided a keynote speech at the OECD Forum on Countering Illicit Trade.

Our Anti-Illicit Trade Expert Group Vice-Chair and AB InBev's Monica Ramirez joined a panel on illicit trade beyond counterfeits.

Our Consumer Policy Committee Vice-Chair and eBay's Delphine Dauba-Pantanacce joined a panel on e-commerce and consumer safety.

Johnson & Johnson's Timothy Mohn had a fireside chat on illicit trade in medical devices.

Intel's Brian White delivered a keynote address at the OECD Forum on Countering Illicit Trade on value of clean and transparent Free Trade Zones..

At the OECD Forum on Countering Illicit Trade, our Executive Director Hanni Rosenbaum provided opening remarks highlighting the importance of public-private partnerships to effectively address the harmful impacts of illicit trade on innovation and economic growth. Members of our global business network including Syngenta, eBay, AB InBev, Amazon, Intel, Johnson & Johnson, Novartis, Maersk, and more contributed to discussions on counterfeits, e-commerce and consumer safety, trade fraud, and medical devices. We look forward to continued engagement with the OECD on illicit trade to ensure its challenges and risks are appropriately addressed.